Literature DB >> 29049746

Degree of pulmonary fissure completeness can predict postoperative cardiopulmonary complications and length of hospital stay in patients undergoing video-assisted thoracoscopic lobectomy for early-stage lung cancer.

Shuangjiang Li1, Kun Zhou1, Mingming Wang1, Rongjia Lin1, Jun Fan1, Guowei Che1.   

Abstract

OBJECTIVES: To estimate the effects of pulmonary fissure completeness on postoperative cardiopulmonary complications (PCCs) and hospital stay in patients undergoing video-assisted thoracoscopic surgery lobectomy for early-stage non-small-cell lung cancer.
METHODS: We performed a single-centre retrospective analysis based on the prospectively maintained data of our institution during the study period. Demographic differences between the PCC group and the non-PCC group were initially examined. Then, the patients were classified into 3 groups according to their fissure sum averages (FSAs: 0 ≤ FSA ≤ 1, 1 < FSA ≤ 2, 2 < FSA ≤ 3) calculated by fissure development scores. The differences in PCC incidences and hospital stay between these 3 groups were further evaluated. Finally, FSA > 1 was determined as the cut-off to indicate the degree of pulmonary fissure completeness and involved into a multivariate logistic regression model to identify the predictors for PCCs.
RESULTS: In total, 528 patients with Stage I to Stage II non-small-cell lung cancer were enrolled. There were 343 patients with 0 ≤ FSA ≤ 1, 105 patients with 1 < FSA ≤ 2 and 80 patients with 2 < FSA ≤ 3. Pulmonary complication rate in patients with 1 < FSA ≤ 2 (25.7% vs 14.3%; P = 0.006) and with 2 < FSA ≤ 3 (33.8% vs 14.3%; P < 0.001) was significantly higher than that in patients with 0 ≤ FSA ≤ 1. No difference was found in cardiovascular complication rate between these groups (P = 0.22). The Kaplan-Meier analysis showed that the length of hospital stay and the length of chest tube drainage in patients with 1 < FSA ≤ 2 and with 2 < FSA ≤ 3 were significantly longer than those in patients with 0 ≤ FSA ≤ 1. Incomplete pulmonary fissure (FSA > 1) was a strong independent predictor for PCCs (odds ratio = 2.12; P = 0.002) in the multivariate analysis.
CONCLUSIONS: The degree of pulmonary fissure completeness can predict the PCCs and the length of hospital stay following video-assisted thoracoscopic surgery lobectomy for early-stage non-small-cell lung cancer.
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Complications; Lobectomy; Non-small-cell lung cancer; Pulmonary fissure completeness; Video-assisted thoracoscopic surgery

Mesh:

Year:  2018        PMID: 29049746     DOI: 10.1093/icvts/ivx261

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  11 in total

1.  Preoperative delineation of pulmonary fissural anatomy at multi-detector computed tomography in children with congenital pulmonary malformations and impact on surgical complications and postoperative course.

Authors:  María Navallas; Priscilla Chiu; Afsaneh Amirabadi; David E Manson
Journal:  Pediatr Radiol       Date:  2020-01-28

2.  Fat-free mass index is superior to body mass index as a novel risk factor for prolonged air leak complicating video-assisted thoracoscopic surgery lobectomy for non-small-cell lung cancer.

Authors:  Shuang-Jiang Li; Zhi-Qiang Wang; Wen-Biao Zhang; Yong-Jiang Li; Shan Cheng; Guo-Wei Che; Lun-Xu Liu
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

3.  Effects of degree of pulmonary fissure completeness on major in-hospital outcomes after video-assisted thoracoscopic lung cancer lobectomy: a retrospective-cohort study.

Authors:  Shuangjiang Li; Zhiqiang Wang; Kun Zhou; Yan Wang; Yanming Wu; Pengfei Li; Guowei Che
Journal:  Ther Clin Risk Manag       Date:  2018-03-02       Impact factor: 2.423

4.  Estimated intraoperative blood loss correlates with postoperative cardiopulmonary complications and length of stay in patients undergoing video-assisted thoracoscopic lung cancer lobectomy: a retrospective cohort study.

Authors:  Shuangjiang Li; Kun Zhou; Yutian Lai; Cheng Shen; Yanming Wu; Guowei Che
Journal:  BMC Surg       Date:  2018-05-23       Impact factor: 2.102

5.  Enhanced recovery programs in lung cancer surgery: systematic review and meta-analysis of randomized controlled trials.

Authors:  Shuangjiang Li; Kun Zhou; Guowei Che; Mei Yang; Jianhua Su; Cheng Shen; Pengming Yu
Journal:  Cancer Manag Res       Date:  2017-11-16       Impact factor: 3.989

6.  Body surface area as a novel risk factor for chylothorax complicating video-assisted thoracoscopic surgery lobectomy for non-small cell lung cancer.

Authors:  Shuangjiang Li; Yan Wang; Kun Zhou; Shan Cheng; Yanming Wu; Guowei Che
Journal:  Thorac Cancer       Date:  2018-10-16       Impact factor: 3.500

7.  Systemic inflammation score: a novel risk stratification tool for postoperative outcomes after video-assisted thoracoscopic surgery lobectomy for early-stage non-small-cell lung cancer.

Authors:  Shuangjiang Li; Zhiqiang Wang; Wenbiao Zhang; Jue Li; Kun Zhou; Guowei Che
Journal:  Cancer Manag Res       Date:  2019-06-21       Impact factor: 3.989

8.  Presence of pleural adhesions can predict conversion to thoracotomy and postoperative surgical complications in patients undergoing video-assisted thoracoscopic lung cancer lobectomy.

Authors:  Shuang-Jiang Li; Kun Zhou; Yan-Ming Wu; Ming-Ming Wang; Cheng Shen; Zhi-Qiang Wang; Guo-Wei Che; Lun-Xu Liu
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

9.  Incidence of venous thromboembolism and bleeding after pulmonary lobectomy: evaluating the timing for thromboprophylaxis.

Authors:  David Smith; Micaela Raices; Carolina Diego; Drago Julián; Juan Montagne; Agustín Dietrich
Journal:  J Thromb Thrombolysis       Date:  2020-09-14       Impact factor: 2.300

10.  Gamma-Glutamyl Transpeptidase to Platelet Ratio Is a Novel and Independent Prognostic Marker for Resectable Lung Cancer: A Propensity Score Matching Study.

Authors:  Liang Zhao; Shuangjiang Li; Juan Ju; Haining Zhou; Hongyu Wang; Guowei Che
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-02-03       Impact factor: 1.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.